Studies on the acute lethality of diethylcarbamazine
in the rat.
treatment of bancroftian and malayan filariasis with emphasis on side effects.
The impact of six rounds of single-dose mass administration of diethylcarbamazine
or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Impact of 10 years of diethylcarbamazine
and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Tolerability and efficacy of single dose albendazole, diethylcarbamazine
(DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study.
Salt fortified with diethylcarbamazine
(DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
The elimination program is based on a simple two drug, once-yearly treatment of at-risk individuals using safe and effective medicines (albendazole plus either Mectizan(R) or diethylcarbamazine
The most widely employed drug in the treatment of lymphatic filariasis for decades has been diethylcarbamazine
POVIDONE iodine 5% v/v 500 ml, STEROID+ANTIFUNGAL+ANTIMICROBS Cream15 Gm, METRONIDAZOL 500 mg Infusion 100 ml, CALCIUM 250 Mg, DIETHYLCARBAMAZINE
100 mg Tab, LACTOBACILLUS 60 mil SPORGENES Tab, ANTACID MPS SYRUP 400 ml Bottle , CEFIXIME 200 mg Tab , LEVOFLOXACIN 500 mg Tab, CHLOROMPHENICOL EYE APLICAP 1%, LOSARTAN POTTASIUM 50 Mg Tab, METFORMIN HYDROCHLORIDE 500 Mg Tab, ATORVASTATIN 10 Mg Tab , METOPROLOL - 50 Mg Tab , ACECLOFENAC 100 Mg Tab , IBUPROFEN +PARA (400+325) Mg Tab, PARACETAMOL 500 Mg, COUGH SYRUP 100 ml, DISODIUM HYDROGENCITRATE Liquid 100 ml,
To achieve this goal annual mass drug administration (MDA) of diethylcarbamazine
(DEC) was launched in 2004 by the Government of India (1,2).
The strategy prescribed for elimination of transmission is mass, annual single dose (6mg/kg body weight) of diethylcarbamazine
(DEC) administration, with or without albendazole (ALB), repeated 4-6 times.
LF has plagued Egypt since the time of the pharaohs; yet this simple strategy -- to provide diethylcarbamazine
(DEC) plus albendazole (donated by GlaxoSmithKline) once a year for five years to the majority of people in affected communities -- reduces infection rates, leading to elimination of the disease.